Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver

Catia Barra; Ana Costa; Gabriela Tavares; Daniela Marques; Tiago Rodrigues; Joana Sacramento; Bernardete Melo; Raquel Seica; Silvia Vilares-Conde; Paulo Matafome

Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver

Catia Barra, Ana Costa, Gabriela Tavares, Daniela Marques, Tiago Rodrigues, Joana Sacramento, Bernardete Melo, Raquel Seica, Silvia Vilares-Conde, Paulo Matafome

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	212-213
Journal	European Journal Of Clinical Investigation
Volume	49
Publication status	Published - Apr 2019

Cite this

@article{be485e277d6141eda24c86acc460f880,

title = "Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver",

author = "Catia Barra and Ana Costa and Gabriela Tavares and Daniela Marques and Tiago Rodrigues and Joana Sacramento and Bernardete Melo and Raquel Seica and Silvia Vilares-Conde and Paulo Matafome",

year = "2019",

month = apr,

language = "English",

volume = "49",

pages = "212--213",

journal = "European Journal Of Clinical Investigation",

issn = "0014-2972",

publisher = "Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Bromocriptine decreases hepatic steatosis by modulation of the dopamine signaling in liver

AU - Barra, Catia

AU - Costa, Ana

AU - Tavares, Gabriela

AU - Marques, Daniela

AU - Rodrigues, Tiago

AU - Sacramento, Joana

AU - Melo, Bernardete

AU - Seica, Raquel

AU - Vilares-Conde, Silvia

AU - Matafome, Paulo

PY - 2019/4

Y1 - 2019/4

M3 - Meeting Abstract

SN - 0014-2972

VL - 49

SP - 212

EP - 213

JO - European Journal Of Clinical Investigation

JF - European Journal Of Clinical Investigation

ER -